After two years, an external body is now to evaluate whether the Danish Medicines Council serves its purpose and its political working conditions. According to co-chairman, the council has made a good start despite challenges on the way.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.